company background image
GSD

Devonian Health Group TSXV:GSD Stock Report

Last Price

CA$0.44

Market Cap

CA$57.8m

7D

7.3%

1Y

-8.3%

Updated

06 Dec, 2022

Data

Company Financials
GSD fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

GSD Stock Overview

Devonian Health Group Inc. engages in the development of botanical drugs.

Devonian Health Group Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Devonian Health Group
Historical stock prices
Current Share PriceCA$0.44
52 Week HighCA$0.68
52 Week LowCA$0.28
Beta1.22
1 Month Change10.00%
3 Month Change-21.43%
1 Year Change-8.33%
3 Year Change183.87%
5 Year Change-12.00%
Change since IPO-45.00%

Recent News & Updates

Is Devonian Health Group (CVE:GSD) Using Debt In A Risky Way?

Dec 01
Is Devonian Health Group (CVE:GSD) Using Debt In A Risky Way?

Recent updates

Is Devonian Health Group (CVE:GSD) Using Debt In A Risky Way?

Dec 01
Is Devonian Health Group (CVE:GSD) Using Debt In A Risky Way?

Is Devonian Health Group (CVE:GSD) Weighed On By Its Debt Load?

Aug 18
Is Devonian Health Group (CVE:GSD) Weighed On By Its Debt Load?

Does Devonian Health Group (CVE:GSD) Have A Healthy Balance Sheet?

Apr 24
Does Devonian Health Group (CVE:GSD) Have A Healthy Balance Sheet?

Does Devonian Health Group's (CVE:GSD) CEO Salary Compare Well With Industry Peers?

Mar 02
Does Devonian Health Group's (CVE:GSD) CEO Salary Compare Well With Industry Peers?

Shareholder Returns

GSDCA PharmaceuticalsCA Market
7D7.3%3.8%-1.5%
1Y-8.3%-46.8%-3.4%

Return vs Industry: GSD exceeded the Canadian Pharmaceuticals industry which returned -40.2% over the past year.

Return vs Market: GSD underperformed the Canadian Market which returned -0.9% over the past year.

Price Volatility

Is GSD's price volatile compared to industry and market?
GSD volatility
GSD Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement14.1%
Market Average Movement9.9%
10% most volatile stocks in CA Market18.2%
10% least volatile stocks in CA Market4.1%

Stable Share Price: Insufficient data to determine GSD's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine GSD's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2015n/aPierre Montanarohttps://groupedevonian.com

Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine, a Phase IIa clinical trial product for the treatment of ulcerative colitis and atopic dermatitis. The company also develops Pantoprazole Magnesium for the treatment of gastric or duodenal ulcers; Cleo-35 for the treatment of hormonal acne in women; and value-added products for dermo-cosmetics.

Devonian Health Group Inc. Fundamentals Summary

How do Devonian Health Group's earnings and revenue compare to its market cap?
GSD fundamental statistics
Market CapCA$57.76m
Earnings (TTM)-CA$3.45m
Revenue (TTM)CA$2.31m

25.1x

P/S Ratio

-16.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
GSD income statement (TTM)
RevenueCA$2.31m
Cost of RevenueCA$1.74m
Gross ProfitCA$561.02k
Other ExpensesCA$4.01m
Earnings-CA$3.45m

Last Reported Earnings

Jul 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.026
Gross Margin24.34%
Net Profit Margin-149.59%
Debt/Equity Ratio26.2%

How did GSD perform over the long term?

See historical performance and comparison